These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients. George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720 [TBL] [Abstract][Full Text] [Related]
6. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Zachary AA; Montgomery RA; Ratner LE; Samaniego-Picota M; Haas M; Kopchaliiska D; Leffell MS Transplantation; 2003 Nov; 76(10):1519-25. PubMed ID: 14657698 [TBL] [Abstract][Full Text] [Related]
10. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients. Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862 [TBL] [Abstract][Full Text] [Related]
11. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. Moazami N; Itescu S; Williams MR; Argenziano M; Weinberg A; Oz MC J Heart Lung Transplant; 1998 Sep; 17(9):876-80. PubMed ID: 9773859 [TBL] [Abstract][Full Text] [Related]
12. [Histocompatibility tests in a transplantation program]. de-Leo-Cervantes C Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052 [TBL] [Abstract][Full Text] [Related]
13. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation]. Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867 [TBL] [Abstract][Full Text] [Related]
14. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Bingaman AW; Murphey CL; Palma-Vargas J; Wright F Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435 [TBL] [Abstract][Full Text] [Related]
15. Peripheral blood B cells producing donor-specific HLA antibodies in vitro. Han M; Rogers JA; Lavingia B; Stastny P Hum Immunol; 2009 Jan; 70(1):29-34. PubMed ID: 19026703 [TBL] [Abstract][Full Text] [Related]
16. Allosensitization to HLA and MICA is an important measure of renal graft outcome. Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK Clin Transpl; 2007; ():211-7. PubMed ID: 18637472 [TBL] [Abstract][Full Text] [Related]
17. [Search for non-relative donor by the Russian register of bone marrow donors]. Zaretskaia IuM; Khamaganova EG; Aleshchenko SM; Murashova LA Ter Arkh; 2002; 74(7):30-5. PubMed ID: 12181831 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin. Zachary AA; Montgomery RA; Leffell MS Hum Immunol; 2005 Apr; 66(4):364-70. PubMed ID: 15866699 [TBL] [Abstract][Full Text] [Related]
19. Myoblast transfer in Duchenne muscular dystrophy. Karpati G; Ajdukovic D; Arnold D; Gledhill RB; Guttmann R; Holland P; Koch PA; Shoubridge E; Spence D; Vanasse M Ann Neurol; 1993 Jul; 34(1):8-17. PubMed ID: 8517684 [TBL] [Abstract][Full Text] [Related]
20. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]